Authors : Dr. Maimako Martins Yakubu; Peter J.; Abdul O.; Okpala-Obanewo T. A.; Goni. B. A.; Maishanu S. H.

Volume/Issue : Volume 11 - 2026, Issue 4 - April

Google Scholar : https://tinyurl.com/284mmb97

Scribd : https://tinyurl.com/4z8brud7

DOI : https://doi.org/10.38124/ijisrt/26apr322

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background: Human immunodeficiency virus (HIV) infection facilitates the acquisition, enhance persistence and also alters the spectrum of human papillomavirus (HPV) infection in HIV infected individuals. The knowledge of the predominant genotypes and associated factors of high-risk human papillomavirus (HrHPV) infection among HIV-positive women is necessary for implementing interventions such as targeted screening for this vulnerable group and developing effective polyvalent HPV vaccine.  Objectives: We determined the predominant HrHPV genotypes and associated risk factors for infection among HIV positive women in Keffi, Nasarawa state, Nigeria.  Methods: In a cross- sectional study, we analyzed the data of 220 HIV positive women who came for routine ART clinic visits. Consenting participants had their socio-demographic and other personal information taken, thereafter cervical sampling was done for each which was used for molecular analysis. Multivariable binary logistic regression models were performed to explore factors associated with HPV infections in the participants.

Keywords : HPV, HIV, Genotypes, High Risk HPV, Vaccination.

References :

1. AdegbesanOmilabu M, Okunade K, Omilabu S. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014;2(2):625.
2. Ashaka OS, Omoare AA, James AB, Adeyemi OO, Oladiji F, Adeniji KA, et al. Prevalence and Risk Factors of Genital Human Papillomavirus Infections among Women in Lagos, Nigeria. Trop Med Infect Dis. 2022 Nov 1;7(11).
3. Okunade KS, Nwogu CM, Oluwole AA, Anorlu RI. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the outpatient clinics of a university teaching hospital in Lagos, Nigeria. Pan Afr Med J. 2017;28:1–7.
4. Aldossary MS, Mufrrih M, El Dalatony MM, Alamri HM. Prevalence and genotypes’ distribution of human papillomavirus among women in Saudi Arabia: a systematic review and meta-analysis. Vol. 13, Frontiers in Public Health. Frontiers Media SA; 2025.
5. Yu H, Yi J, Dou YL, Chen Y, Kong LJ, Wu J. Prevalence and genotype distribution of human papillomavirus among healthy females in beijing, china, 2016–2019. Infect Drug Resist. 2021;14:4173–82.
6. Banura C, Franceschi S, Van Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, et al. Infection with human papillomavirus and HIV among young women in Kampala, Uganda. J Infect Dis. 2008;197(4):555–62.
7. Liu G, Sharma M, Tan N, Barnabas R. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta-analysis. Aids. 2018;176(1):100–106.
8. Swai P, Rasch V, Linde DS, Mchome B, Manongi R, Wu C Sen, et al. Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study. Infect Agent Cancer [Internet]. 2022;17(1):1–11. Available from: https://doi.org/10.1186/s13027-022-00442-2
9. Maranga IO. HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women. Open Virol J. 2013;7(1):19–27.
10. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J, Hughes TK, et al. Nested PCR with the PGMY09/11 and GP5 +/6 + primer sets improves detection of HPV DNA in cervical samples. J Virol Methods. 2004;122(1):87–93.
11. OKUNADE KS, BADMOS KB, OKORO A, AWOLOLA NA, NWAOKORIE FO, ADELABU H, et al. Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria. Res Sq [Internet]. 2024;rs.3.rs-4645178. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11275992/
12. Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S, et al. Epidemiology of HPV genotypes among HIV positive women in Kenya: A systematic review and meta-analysis. PLoS One. 2016;11(10).
13. Traore B, Kassogue Y, Diakite B, Diarra F, Cisse K, Kassogue O, et al. Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study. BMC Infect Dis [Internet]. 2024;24(1):1–8. Available from: https://doi.org/10.1186/s12879-024-09412-y
14. Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis [Internet]. 2013;13(1):1. Available from: BMC Infectious Diseases
15. Han S, Lin M, Liu M, Wu S, Guo P, Guo J, et al. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med [Internet]. 2025;23(1). Available from: https://doi.org/10.1186/s12916-025-03975-6
16. Martins AES, Lucena-Silva N, Garcia RG, Welkovic S, Barboza A, Menezes MLB, et al. Prevalence of human papillomavirus infection, Distribution of viral types and risk factors in cervical samples from human immunodeficiency virus-positive women attending three human immunodeficiency virus-acquired immune deficiency syndrome reference cent. Mem Inst Oswaldo Cruz. 2014;109(6):738–47.
17. Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, et al. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis. 2006;194(4):428–34.
18. Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, Read JS, et al. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010;55(2):197–204.
19. Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IAO, Odberg Pettersson K. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014;11(1):1–11.